Kolon TissueGene, Inc.

₩13,110As of Sun 8 Nov 2026, 12:00 UTC
KOSDAQ:950160Healthcare
Country South Korea
PE (Fwd) •••
TSR 4Y CAGR (3.61%)
Div yield —
ROE (113.08%)
Biotechnology
Beta (5Y) (0.26)
PE TTM —
TSR TTM (70.74%)
Mkt cap ₩1.114T
ROIC (7.02%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
₩13,852
5.66%
(82.00%)
Hold 5|0|2|11|9
4Q25
1Q26
2Q26
3Q26
Earnings per share₩
288.44
308.70
333.80
329.90
29.67%
36.99%
33.22%
19.78%
Revenue₩B
72.50
71.81
74.95
77.89
17.73%
13.56%
12.22%
12.00%
Peers (US$821.3M)
Cap (US$)
PE
822.8M
197.9x
Capital
TTM
5Y
10Y
Leveragex
0.474
(1.251)
(0.899)
EBIT/Intx
1.524
0.093
0.098
Own earn%
256.94
(35.60)
(13.14)
Sh yield%
30.68
26.81
26.05
Owners
Insiders/Inst%
5.80
57.56
Short interest%
4.85
SBC / revenue%
2.30
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
1
Op margin range%
9–15
$1 testx
0.7
Incr. ROIC%
5